Investigation Into MacroGenics (MGNX) Announced by Hagens Berman

"We're investigating whether MacroGenics may have misled investors about its Phase 2 TAMARACK interim safety data," said Reed Kathrein, the Hagens Berman partner leading the investigation. Contact: Reed Kathrein, 844-916-0895 SAN FRANCISCO, July 19, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges MacroGenics, Inc. (NASDAQ: MGNX) investors who suffered substantial losses to submit your losses now. Investigation into MacroGenics, Inc. (MGNX): On Apr. 3, 2024, MacroGenics released interim safety data from the TAM ...